HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Detrusor instability in children with recurrent urinary tract infection and/or enuresis. II. Treatment.

Abstract
Of 41 children, aged 5-15 years, referred consecutively because of recurrent urinary tract infections (UTIs) and/or enuresis, 18 (44%) showed detrusor instability (DI) in at least 2 of 6 CO2 cystometries. One child was excluded from the study because of lack of follow-up. Four children with less pronounced DI (instability during less than or equal to 50% of the cystometries performed) and frequent UTIs were given antibiotics prophylactically for 3 months. In the remaining 13 children, DI was found during more than half the cystometries performed, and 11 of these children, who also had urge incontinence, were treated with emepronium bromide, 400-600 mg daily (10-12 mg/kg) for 3 months. In 7 of the patients this treatment was supplemented by antibiotics prophylactically because of frequent UTIs. Two children with special problems received other types of treatment. All children were free from symptoms at a clinical check-up 6 months later, 95% confidence limits 0-20%.
AuthorsN Qvist, K K Nielsen, E S Kristensen, D Ehlers, K M Jensen, T Krarup, J Christoffersen
JournalUrologia internationalis (Urol Int) Vol. 41 Issue 3 Pg. 199-201 ( 1986) ISSN: 0042-1138 [Print] Switzerland
PMID3750582 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Emepronium
Topics
  • Adolescent
  • Anti-Bacterial Agents (therapeutic use)
  • Child
  • Child, Preschool
  • Cystoscopy
  • Emepronium (therapeutic use)
  • Enuresis (drug therapy, etiology, physiopathology)
  • Female
  • Humans
  • Male
  • Muscle, Smooth (physiopathology)
  • Urinary Bladder (physiopathology)
  • Urinary Bladder Diseases (complications, drug therapy)
  • Urinary Tract Infections (drug therapy, etiology, physiopathology)
  • Urodynamics

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: